Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: Two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma

American Journal of Surgical Pathology

Volumn 39, Issue 7, 2015, Pages 889-901

  Deml, Karl Friedrich ^a   Schildhaus, Hans Ulrich ^e   Compérat, Eva ⁿ   Von Teichman, Adriana ^a   Storz, Martina ^a   Schraml, Peter ^a   Bonventre, Joseph V ^o   Fend, Falko ^f   Fleige, Barbara ^g   Nerlich, Andreas ^h   Gabbert, Helmut E ⁱ   Gabler, Nikolaus ^j   Grobholz, Rainer ^b   Hailemariam, Seife ^c   Hinze, Raoul ^k   Knüchel, Ruth ^j   Lhermitte, Benoit ^d   Nesi, Gabriella ^p   Rüdiger, Thomas ^l   Sauter, Guido ^m   Moch, Holger ^a   more..

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c Institute for Histological and Cytological Diagnostics   (Switzerland)

^d UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g HELIOS Hospital Berlin Buch   (Germany)

^h Munich Municipal Hospital   (Germany)

ⁱ UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^j RWTH AACHEN UNIVERSITY   (Germany)

^k HELIOS KLINIKEN SCHWERIN   (Germany)

^l STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o BRIGHAM AND WOMEN S HOSPITAL   (United States)

^p UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

clear cell papillary renal cell cancer; clear cell renal cell carcinoma; cytokeratin 7; kidney; renal angiomyoadenomatous tumor; VHL

Indexed keywords

ADULT; AGED; CLASSIFICATION; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 84933527121     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000456     Document Type: Article

References (60)

1. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37:1469-1489.
2. Tickoo SK, de Peralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153.
3. Adam J, Couturier J, Molinie V, et al. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology. 2011;58:1064-1071.
4. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608-1621.
5. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
6. Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol. 2011;24:1207-1220.
7. Williamson SR, Eble JN, Cheng L, et al. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohisto-chemical profile. Mod Pathol. 2013;26:697-708.
8. Herrera LP, Hirsch M, Comperat E, et al. Clear cell-papillary renal cell carcinoma (CP-RCC) not associated with end stage renal disease: clinicopathologic analysis of 50 tumors confirming a novel subtype of renal cell carcinoma (RCC) occurring in a sporadic setting. Mod Pathol. 2011;24(suppl):197A.
9. Wolfe A, Dobin SM, Grossmann P, et al. Clonal trisomies 7, 10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch. 2011;459: 457-463.
10. Kuroda N, Shiotsu T, Kawada C, et al. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol. 2011;15:282-285.
11. Michal M, Hes O, Havlicek F. Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor. Ann Diagn Pathol. 2000;4:311-315.
12. Michal M, Hes O, Nemcova J, et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454:89-99.
13. Verine J. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454:479-480.
14. Shannon BA, Cohen RJ, Segal A, et al. Clear cell renal cell carcinoma with smooth muscle stroma. Hum Pathol. 2009;40: 425-429.
15. Kuhn E, De Anda J, Manoni S, et al. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: report of 5 cases and review of the literature. Am J Surg Pathol. 2006;30:1372-1381.
16. Singh C, Kendi AT, Manivel JC, et al. Renal angiomyoadenoma-tous tumor. Ann Diagn Pathol. 2012;16:470-476.
17. Martignoni G, Brunelli M, Segala D, et al. Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations. Mod Pathol. 2014;27:765-74.
18. Behdad A, Monzon FA, Hes O, et al. Relationship between sporadic clear cell-papillary renal cell carcinoma (CP-RCC) and renal angiomyoadenomatous tumor (RAT) of the kidney: analysis by virtualkaryotyping, fluorescent in situ analysis and immunohistochemistry (IHC). Mod Pathol. 2011;24(suppl):179A.
19. Michal M, Hes O, Kuroda N, et al. Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma. Virchows Arch. 2009;454:719.
20. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer-Verlag; 2010.
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-663.
22. Schildhaus HU, Deml KF, Schmitz K, et al. Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung. Mod Pathol. 2013;26: 1468-1477.
23. Sanjmyatav J, Hauke S, Gajda M, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol. 2013;64:689-691.
24. Pflueger D, Sboner A, Storz M, et al. Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia. 2013;15:1231-1240.
25. von Teichman A, Comperat E, Behnke S, et al. VHL mutations and dysregulation of pVHL-and PTEN-controlled pathways in multi-locular cystic renal cell carcinoma. Mod Pathol. 2011;24:571-578.
26. Cui C, Lal P, Master S, et al. Expression of parafibromin in major renal cell tumors. Eur J Histochem. 2012;56:e39.
27. Aron M, Zhang P, De Peralta-Venturina M, et al. Expression of novel markers human kidney injury molecule-1 (Hkim-1), S100A1 and napsin A in the differential diagnosis of renal cell carcinomas (RCC) with clear and papillary features. Mod Pathol. 2012;25(suppl): 190A.
28. Schwartz JD, Amin MB, Zhang PL. Immunohistochemical profile of stem/progenitor cell marker CD133 in variants of renal tumors. Mod Pathol. 2012;25(suppl):240A.
29. Lin F, Zhang PL, Yang XJ, et al. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol. 2007;31:371-381.
30. Ruf M, Mittmann C, Nowicka AM, et al. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ Lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clin Cancer Res. 2015;21:889-98.
31. Choi JS, Kim MK, Seo JW, et al. MET expression in sporadic renal cell carcinomas. J Korean Med Sci. 2006;21:672-677.
32. Cai J. Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma. Exp Ther Med. 2013; 6:1489-1493.
33. Tickoo SK, Reuter VE. Differential diagnosis of renal tumors with papillary architecture. Adv Anat Pathol. 2011;18:120-132.
34. Zhou H, Zheng S, Truong LD, et al. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol. 2014;45:59-64.
35. Gill S, Kandel S, Xu B. Frequency of clear cell papillary renal cell carcinoma in cases of low grade clear cell renal cell carcinoma: a 12 year retrospective study from a single cancer center. Mod Pathol. 2013;26(suppl):212A.
36. Shi SS, Shen Q, Xia QY, et al. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. Int J Clin Exp Pathol. 2013;6:2936-2942.
37. Green WM, Yonescu R, Morsberger L, et al. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol. 2013;37:1150-1163.
38. Argani P, Yonescu R, Morsberger L, et al. Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol. 2012;36:1516-1526.
39. Smith NE, Illei PB, Allaf M, et al. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol. 2014;38:604-614.
40. Petersson F, Grossmann P, Hora M, et al. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. Hum Pathol. 2013;44:1412-1420.
41. Xu W, Deng F-M, Melamed J, et al. Incidence and genetic characteristics of clear cell tububopapillary renal cell carcinoma. Mod Pathol. 2014;27(suppl):270A.
42. Behdad A, Hes O, Hirsch M, et al. Relationship between sporadic clear cell-papillary renal cell carcinoma (CP-RCC) and renal angiomyoadenomatous tumor (RAT) of the kidney: analysis by virtual-karyotyping, fluorescent in situ analysis and immunohistochemistry (IHC). Mod Pathol. 2011;24(suppl):179A.
43. Martignoni G, Segala D, Borze I, et al. VHL mutation, VHL methylation, chromosome 3p and whole genomic status in clear cell papillary renal cell carcinoma. Mod Pathol. 2013;26(suppl):233A.
44. Rechsteiner MP, von Teichman A, Nowicka A, et al. VHL gene mutations and their effects on hypoxia inducible factor HIFalpha: identification of potential driver and passenger mutations. Cancer Res. 2011;71:5500-5511.
45. Young AC, Craven RA, Cohen D, et al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin Cancer Res. 2009;15: 7582-7592.
46. Halat S, Eble JN, Grignon DJ, et al. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol. 2010;23:931-936.
47. Mertz KD, Demichelis F, Sboner A, et al. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer. 2008;123: 569-576.
48. Nickerson ML, Jaeger E, Shi Y, et al. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 2008;14:4726-4734.
49. Lawrie CH, Larrea E, Larrinaga G, et al. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes. J Pathol. 2014;232: 32-42.
50. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 1997;16:68-73.
51. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910-14914.
52. Fisher KE, Yin-Goen Q, Alexis D, et al. Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. 2014;27:222-230.
53. Alexiev BA, Drachenberg CB. Clear cell papillary renal cell carcinoma: incidence, morphological features, immunohistochem-ical profile, and biologic behavior: a single institution study. Pathol Res Pract. 2014;210:234-241.
54. Guo J, Tretiakova MS, Troxell ML, et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014;38: 1457-1467.
55. Boysen G, Bausch-Fluck D, Thoma CR, et al. Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia. 2012;14:535-546.
56. Williamson SR, Zhang S, Eble JN, et al. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2013;37:1131-1139.
57. Munari E, Segala D, Gobbo S, et al. GATA3 expression in clear cell papillary renal cell carcinoma and renal cell carcinoma with prominent leiomyomatous proliferation is a further evidence of the relationship between these two entities. Mod Pathol. 2014;27(suppl): 250A.
58. Leroy X, Camparo P, Gnemmi V, et al. Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with over-expression of cyclin-D1. Histopathology. 2014;64:1032-1036.
59. Williamson SR, Halat S, Eble JN, et al. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol. 2012;36: 1425-1433.
60. Dahinden C, Ingold B, Wild P, et al. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res. 2010;16:88-98.